An appreciation of tissue complexity in disorders such as cancer has led researchers to develop multiplex immunohistochemistry methods (mIHC), where dozens of markers are assayed on a single slide.

Immunohistochemistry (IHC) has continually evolved alongside technological and scientific advances. Because scientists constantly develop and modify their IHC techniques to better answer modern ...

Cell IDx's UltraPlex multiplex technology enables high throughput multiplex fluorescent and multiplex chromogenic IHC biomarker tissue profiling for both preclinical and translational research. The ...

The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...

Despite widespread provision of Lynch syndrome (LS) screening programs, questions remain about the most effective and efficient protocol for LS case finding. The purpose of this study was to explore ...

Leica Biosystems, unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system engineered to simplify assay setup and reduce variability. ChromoPlex III ...

Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /PRNewswire/ -- Definiens, a leading ...